niclosamide has been researched along with Clostridioides difficile Infection in 1 studies
Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
niclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tam, J | 1 |
| Hamza, T | 1 |
| Ma, B | 1 |
| Chen, K | 1 |
| Beilhartz, GL | 1 |
| Ravel, J | 1 |
| Feng, H | 1 |
| Melnyk, RA | 1 |
1 other study available for niclosamide and Clostridioides difficile Infection
| Article | Year |
|---|---|
Host-targeted niclosamide inhibits C. difficile virulence and prevents disease in mice without disrupting the gut microbiota.
Topics: Animals; Anticestodal Agents; Bacterial Toxins; Caco-2 Cells; Cell Line; CHO Cells; Clostridioides d | 2018 |